This MedLibrary.org supplementary page on Orion Pharma is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
 |
|
| Type | Public (OMX: ORNBV) |
|---|---|
| Founded | 1917 |
| Headquarters | Espoo, Finland |
| Key people | Timo Lappalainen (President and CEO), Matti Kavetvuo (Chairman of the board) |
| Industry | Pharmaceutics |
| Products | Pharmaceuticals, active pharmaceutical ingredients and diagnostic tests |
| Revenue | €683.6 million (2007)[1] |
| Operating income | ▲ €194 million (2007)[1] |
| Employees | 3,170 (2007)[1] |
| Website | www.orion.fi |
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company has also a large R&D unit in Turku.
Orion has annual net sales of approximately EUR 500 million; its class A and B shares are listed on the Helsinki Stock Exchange.
References
External links
Wikipedia content modification information:
- This page was last modified on 6 October 2008, at 01:44.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Orion Pharma".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.